Proactive Care
Natural health product licensed in Canada
- Other names
- LIVLI
- Licence holder
- Folium Labs Inc.
- NPN or DIN-HM
- 80088350
- Status
- Active licence
- Licence date
- 13 September 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Manganèse: up to 5 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Ginkgo biloba - feuille | 75 mg | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : N-acétyl L-chlorhydrate de carnitine | 25 mg | Not calculated |
| L-Tyrosine Source : L-Tyrosine | 25 mg | Not calculated |
| Riboflavine Source : Riboflavine | 4 mg | 8,000 µg |
| Ocimum tenuiflorum Source : Ocimum tenuiflorum - feuille | 25 mg | Not calculated |
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 30 mg | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 8 mg | 16,000 µg |
| Bacopa monnieri Source : Bacopa monnieri - Sommité (herbe) | 25 mg | Not calculated |
| Acide 2-aminoéthanesulfonique Source : Taurine | 25 mg | Not calculated |
| Withania somnifera Source : Withania somnifera - racine | 25 mg | Not calculated |
| Manganèse Source : Manganèse | 2.5 mg | 5,000 µg |
| Silybum marianum Source : Silybum marianum - Fruit | 50 mg | Not calculated |
| Niacinamide Source : Niacinamide | 7.5 mg | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 100 mcg | 200 µg |
| Thiamine Source : Thiamine HCl | 4 mg | 8,000 µg |
| Magnésium Source : Glycinate de magnésium | 25 mg | 50,000 µg |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 day |
Uses authorised in Canada
Helps to maintain cognitive function. Helps in energy production and metabolism. Source of antioxidant. Supports and maintain immune system. Helps to support liver function. Helps to maintain bone health and heart muscle.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you have a history of non-melanoma skin cancer, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are following a low protein diet. If symptoms persist or worsen, consult a health care practitioner. If you are taking blood thinners or digoxin, antidepressant medication, medications for diabetes, high blood pressure, or seizures or hormone replacement therapy (HRT) or birth control pills, consult a health care practitioner prior to use. If you experience severe stomach and/or intestinal irritation, discontinue use. If you have liver disease, kidney disease and/or a seizure disorder, consult a health care practitioner prior to use. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended. People sensitive to niacinamide may experience flushing of the skin that is generally mild and transient. Consult a health care practitioner prior to use if you are taking antidepressant medications. Consult a health care practitioner prior to use if you have diabetes.
- Effets indésirables connus
Folate supplementation can mask a vitamin B12 deficiency. If you are unsure whether you are taking enough vitamin B12, consult a health care practitioner prior to use. If you experience irritability or insomnia or headche, discontinue use. May cause digestive problems.
- Contre-indications
If you have bipolar disorder or bipolar spectrum disorder, do not use this product. Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding. Do not use if you are pregnant or breastfeeding. If you are taking antibiotics, do not use this product. If you are taking nitroglycerin, do not use this product.
Source
Official Health Canada record, licence 80088350
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.